The Pharma Data

FEBRUARY 8, 2021

Dose interruption, dose reduction, or delay in starting treatment cycles is recommended for patients who develop Grade 3 or 4 neutropenia. In patients who have new or worsening respiratory symptoms and are suspected to have developed pneumonitis, interrupt IBRANCE immediately and evaluate the patient. hypoxia, cough, dyspnea).

HR 52

HR Clinical Trials Clinical Trials Containment 52

The Pharma Data

MARCH 25, 2021

Chief Development Officer, Oncology, Pfizer Global Product Development. Dose interruption, dose reduction, or delay in starting treatment cycles is recommended for patients who develop Grade 3 or 4 neutropenia. IBRANCE may impair fertility in males and has the potential to cause genotoxicity. hypoxia, cough, dyspnea).

HR 52

HR Clinical Trials Clinical Trials Trials 52

The Pharma Data

MAY 13, 2021

Fructose as a key player in the development of fatty liver disease. Exposure to sorbitol during lactation causes metabolic alterations and genotoxic effects in rat offspring. How does brain insulin resistance develop in Alzheimer’s disease? Dietary Fructose and Metabolic Syndrome and Diabetes. The Journal of Nutrition.

Insulin 52

Insulin Production Hormones Medicine 52